Willl The Vaccine Work Against The New Strain of COVID-19? Experts Have an Answer

Willl The Vaccine Work Against The New Strain of COVID-19? Experts Have an Answer
SHARE

The world is alarmed by a new strain of COVID-19 that spreads rapidly in the UK, as it makes the pandemic virus even more infectious than before. Although there’s a vaccine for COVID-19, many had been wondering how well will the drug do against the new variant of the coronavirus.

The vaccine developed by Pfizer is already approved and distributed to patients of the USA, the world’s most affected country by the COVID-19 pandemic. Canada and the UK also approved the vaccine, while many other countries are eagerly waiting for the full authorization of the drug.

The Pfizer vaccine will also work against the new strain of COVID-19

Vin Gupta, who is an affiliate assistant professor from the Institute for Health Metrics and Evaluation at the University of Washington, brings us great news. He says that the vaccine will also work against the newly discovered strain of the coronavirus, and he motivates his claim by saying that emerging strains will most likely be genetically similar to prior ones. Gupta also declared:

There is a strong belief here that the vaccine, as it exists today … will have effectiveness in warding off infection from this new strain in England, in addition to the old strain that we’ve been contending with for months now.

The new strain of the coronavirus that’s unfolding has caused several other countries to forbid flights from the UK, such as Germany, Canada, Israel, and more. Vin Gupta has a lot of faith in the vaccine developed by Pfizer, as he also added:

The effectiveness of these vaccines in producing antibodies that can really attack and kill Covid-19 is extraordinary.

Dr Vivek Murthy, who is expected to be the next U.S. Surgeon General, declared:

There’s no reason to believe that the vaccines that have been developed will not be effective against [the new U.K. strain] as well.

During the clinical trials, the vaccine developed by Pfizer reported an efficacy rate of about 95%, which grants a lot of hope that the ongoing pandemic is approaching its end.


SHARE

Anna is an avid blogger with an educational background in medicine and mental health. She is a generalist with many other interests including nutrition, women's health, astronomy and photography. In her free time from work and writing, Anna enjoys nature walks, reading, and listening to jazz and classical music.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.